This study investigated the relationship between the diagnosis of rheumatoid arthritis (RA) and the development of lung diseases (LDs) over five years. 

The study showed that the markers of RA activity were associated with the development of lung disease.

This study looked at the treatment of poorly-controlled type 2 diabetics. They found that a combination of exenatide and dapagliflozin was more effective at lowering blood glucose (sugar) than either treatment alone.

This study looked at the safety and benefits of starting sotagliflozin (Zynquista) in patients with type 2 diabetes (T2D) who were recently hospitalized for heart failure. They found that patients started on sotagliflozin within 2 days of discharge from the hospital had a lower risk of serious complications including heart-related hospitalization or death.

This study compared the use of steroid eye injections with other treatments for diabetic macular edema (DME). They found that steroid injections may improve vision slightly compared to placebo, but are possibly less effective than other types of injection. Steroid injections also increase the risk of cataracts and increased pressure in the eye.

This study investigated the effect of disease-modifying anti-rheumatic drugs (DMARDs) on cardiovascular disease (CVD) risk.

They found that abatacept (Orencia) and tumor necrosis factor inhibitors (TNFi) were associated with decreased CVD risk.

This study looked at the safety and effectiveness of adding dapagliflozin (Forxiga) in poorly controlled type 1 diabetes (T1D). It found that patients treated with dapagliflozin had better blood glucose (sugar) control and more weight loss after 12 months than patients treated with placebo.

This study compared the safety of two medications, linagliptin (Trajenta) and glimepiride (Amaryl). It found that the medications had the same risk of heart attack, stroke, or heart-related death, while linagliptin was associated with a lower risk of hypoglycemia (dangerously low blood glucose level).

This review looked at the effect of a fiber-rich diet on the microbiome for patients with diabetes. It found that high-fiber diets led to more healthy bacteria in the gut, and may improve glucose control.

This study reviewed infection risk in patients treated with biologic and targeted disease-modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA).

This study investigated the effect of baricitinib (Olumiant) on biomarkers in the blood, which indicate a state of joint destruction in patients with moderate to severe rheumatoid arthritis (RA).

The study showed that baricitinib reduced these biomarkers and resulted in decreased RA symptoms.